Scientific article
OA Policy
English

Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study

Published inHIV Medicine, vol. 19, no. 8, p. 572-577
Publication date2018
Abstract

Dolutegravir (DTG) is a highly effective integrase inhibitor with a strong genetic resistance barrier and a potential role in simplified HIV maintenance treatment. We assessed the feasibility of DTG maintenance monotherapy and measured HIV reservoirs on DTG monotherapy.

Keywords
  • HIV
  • HIV reservoirs
  • Dolutegravir
  • Maintenance therapy
  • Simplification
Funding
  • Swiss National Science Foundation - 324730‐165956
Citation (ISO format)
SCULIER, Delphine et al. Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study. In: HIV Medicine, 2018, vol. 19, n° 8, p. 572–577. doi: 10.1111/hiv.12626
Main files (1)
Article (Published version)
Identifiers
Journal ISSN1464-2662
340views
147downloads

Technical informations

Creation22/09/2020 10:50:00
First validation22/09/2020 10:50:00
Update09/02/2026 15:28:30
Status update09/02/2026 15:28:30
Last indexation09/02/2026 15:33:45
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack